Friday, December 19, 2008

Life Sciences Discovery Fund Gives $4.7M To Vaccine Research

Seattle-based Washington Life Sciences Discovery Fund (LSDF) said this week that it has awarded nearly $4.7M to the Washington Vaccine Alliance (WAVA), for a program to help research new vaccines for E. coli, herpes and syphilis. The program will be operated at the Vaccine and Infectious Disease Institute of Fred Hutchinson Cancer Research Center. The funding comes from Washington's $350M tobacco lawsuit settlement. WAVA includes Battelle Pacific Northwest Division, Infectious Disease Research Institute (IDRI), PATH, Seattle Biomedical Research Institute (SBRI), University of Washington (UW), and Washington State University (WSU).